{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:31:23Z","timestamp":1791919883103,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Govt. of India","doi-asserted-by":"publisher","award":["IF120584"],"award-info":[{"award-number":["IF120584"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.cbi.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T13:31:59Z","timestamp":1457616719000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["Chrysin, a PPAR-\u03b3 agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation"],"prefix":"10.1016","volume":"250","author":[{"given":"Neha","family":"Rani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagriti","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruma","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharamvir Singh","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2016.03.015_bib1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2016.03.015_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature","volume":"106","author":"Yan","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2016.03.015_bib3","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.3390\/ijms141019891","article-title":"Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond","volume":"14","author":"Daffu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2016.03.015_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20130065","article-title":"Nox as a target for diabetic complications","volume":"125","author":"Gorin","year":"2013","journal-title":"Clin. Sci. Lond."},{"key":"10.1016\/j.cbi.2016.03.015_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.cbi.2016.03.015_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dmrr.2560","article-title":"AGEs and chronic subclinical inflammation in diabetes: disorders of immune system","volume":"31","author":"Hu","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cbi.2016.03.015_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/diacare.25.6.1055","article-title":"Advanced glycation end products and endothelial dysfunction in type 2 diabetes","volume":"25","author":"Tan","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2016.03.015_bib8","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2174\/13816128113199990475","article-title":"Role of AGEs-RAGE system in cardiovascular disease","volume":"20","author":"Fukami","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cbi.2016.03.015_bib9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2337\/db07-0326","article-title":"RAGE and modulation of ischemic injury in the diabetic myocardium","volume":"57","author":"Bucciarelli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2016.03.015_bib10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/db07-1808","article-title":"Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes","volume":"57","author":"Soro-Paavonen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2016.03.015_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/db13-1864","article-title":"Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL)","volume":"64","author":"Hanssen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2016.03.015_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.phrs.2009.01.006","article-title":"Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease","volume":"60","author":"Yamagishi","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2016.03.015_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00395-009-0071-x","article-title":"Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor","volume":"105","author":"Ihm","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cbi.2016.03.015_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/092986608785203746","article-title":"Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation","volume":"15","author":"Yamagishi","year":"2008","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.cbi.2016.03.015_bib15","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3892\/mmr.2014.3113","article-title":"Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells","volume":"11","author":"Di","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2016.03.015_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-5793(01)02393-6","article-title":"Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages","volume":"496","author":"Liang","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2016.03.015_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bcp.2014.03.016","article-title":"Chrysin attenuates inflammation by regulating M1\/M2 status via activating PPAR\u03b3","volume":"89","author":"Feng","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2016.03.015_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1142\/S0192415X14500724","article-title":"Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-\u03b3 activation","volume":"42","author":"El-Bassossy","year":"2014","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.cbi.2016.03.015_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12986-015-0004-7","article-title":"Inhibition of TGF-\u03b2 by a novel PPAR-\u03b3 agonist, chrysin, salvages \u03b2-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism","volume":"12","author":"Rani","year":"2015","journal-title":"Nutr. Metab. Lond."},{"key":"10.1016\/j.cbi.2016.03.015_bib20","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ptr.4917","article-title":"Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation","volume":"27","author":"El-Bassossy","year":"2013","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cbi.2016.03.015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2014.05.007","article-title":"Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats","volume":"279","author":"Ahad","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.03.015_bib22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI106180","article-title":"Diabetogenic action of streptozotocin: relationship of dose to metabolic response","volume":"48","author":"Junod","year":"1969","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.cbi.2016.03.015_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","article-title":"Challenges and issues with streptozotocin-induced diabetes - a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics","volume":"244","author":"Goyal","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.03.015_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2016.03.015_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2016.03.015_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2016.03.015_bib27","series-title":"Methods of Enzymatic Analysis","first-page":"673","article-title":"Catalase","author":"Aebi","year":"1974"},{"key":"10.1016\/j.cbi.2016.03.015_bib28","doi-asserted-by":"crossref","first-page":"e82577","DOI":"10.1371\/journal.pone.0082577","article-title":"Regulation of heat shock proteins 27 and 70, p-Akt\/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in\u00a0vivo after ischemia\/reperfusion","volume":"8","author":"Rani","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.cbi.2016.03.015_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10495-014-1083-z","article-title":"5-HT2B receptor blockade attenuates \u03b2-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs","volume":"20","author":"Bharti","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2016.03.015_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00210-004-0964-z","article-title":"Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels","volume":"370","author":"Calderone","year":"2004","journal-title":"NaunynSchmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2016.03.015_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000081807","article-title":"Effects of the dietary flavonoid chrysin in isolated rat mesenteric vascular bed","volume":"41","author":"Villar","year":"2004","journal-title":"J.\u00a0Vasc. Res."},{"key":"10.1016\/j.cbi.2016.03.015_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.yjmcc.2008.03.021","article-title":"The PPAR trio: regulators of myocardial energy metabolism in health and disease","volume":"44","author":"Madrazo","year":"2008","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2016.03.015_bib33","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1194\/jlr.R024505","article-title":"PPAR-\u03b3 as a therapeutic target in cardiovascular disease: evidence and uncertainty","volume":"53","author":"Huang","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.03.015_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2016.03.015_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1211\/jpp.61.06.0015","article-title":"Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats","volume":"61","author":"Sathiavelu","year":"2009","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2016.03.015_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11010-013-1819-z","article-title":"Evaluation of the anti-atherogenic potential of chrysin in Wistar rats","volume":"385","author":"Anandhi","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2016.03.015_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2014.01.065","article-title":"Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis","volume":"728","author":"Mantawy","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2016.03.015_bib38","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.3390\/ijms150711510","article-title":"Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages","volume":"15","author":"Warat","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2016.03.015_bib39","first-page":"11641","article-title":"Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity","volume":"26","author":"Anghel","year":"2015","journal-title":"Histol. Histopathol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716300783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716300783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:39:30Z","timestamp":1757857170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279716300783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":39,"alternative-id":["S0009279716300783"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2016.03.015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chrysin, a PPAR-\u03b3 agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}